Related references
Note: Only part of the references are listed.Prescription of CRRT: a pathway to optimize therapy
Ayman Karkar et al.
ANNALS OF INTENSIVE CARE (2020)
Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference
Marlies Ostermann et al.
KIDNEY INTERNATIONAL (2020)
Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury A Randomized Clinical Trial
Alexander Zarbock et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis
Wei Zhang et al.
CRITICAL CARE (2019)
Hyperlactatemia, Lactate Kinetics and Prediction of Citrate Accumulation in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy With Regional Citrate Anticoagulation
Dmytro Khadzhynov et al.
CRITICAL CARE MEDICINE (2017)
Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs
Ming Bai et al.
INTENSIVE CARE MEDICINE (2015)
Ionized calcium measurements during regional citrate anticoagulation in CRRT: we need better blood gas analyzers
Detlef Kindgen-Milles et al.
CRITICAL CARE (2015)
Regional Citrate Anticoagulation for RRTs in Critically Ill Patients with AKI
Santo Morabito et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
A Target-Oriented Algorithm for Citrate-Calcium Anticoagulation in Clinical Practice
Karin Strobl et al.
BLOOD PURIFICATION (2013)
Bioenergetic gain of citrate anticoagulated continuous hemodiafiltration-a comparison between 2 citrate modalities and unfractionated heparin
Martin Balik et al.
JOURNAL OF CRITICAL CARE (2013)
Bivalirudin versus Unfractionated Heparin for Prevention of Hemofilter Occlusion During Continuous Renal Replacement Therapy
Tyree H. Kiser et al.
PHARMACOTHERAPY (2010)
Heparin algorithm for anticoagulation during continuous renal replacement therapy
Marlies Ostermann et al.
CRITICAL CARE (2010)
Argatroban for anticoagulation in continuous renal replacement therapy
Andreas Link et al.
CRITICAL CARE MEDICINE (2009)
Enoxaparin vs. unfractionated heparin for anticoagulation during continuous veno-venous hemofiltration: a randomized controlled crossover study
Michael Joannidis et al.
INTENSIVE CARE MEDICINE (2007)
Citrate plasma levels in patients under regional anticoagulation in continuous venovenous hemofiltration
Gerd R. Hetzel et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy
BV Reddy et al.
ANNALS OF PHARMACOTHERAPY (2005)
Argatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia
IY Tang et al.
ANNALS OF PHARMACOTHERAPY (2005)
Citrate anticoagulation for extracorporeal circuits: Effects on whole blood coagulation activation and clot formation
A Calatzis et al.
NEPHRON (2001)
Heparin and low-molecular-weight heparin - Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety
J Hirsh et al.
CHEST (2001)
Nadroparin versus dalteparin anticoagulation in high-volume, continuous venovenous hemofiltration: A double-blind, randomized, crossover study
ACJM de Pont et al.
CRITICAL CARE MEDICINE (2000)
Share Paper
